Spandidos Publications style
Kataoka J, Shiraha H, Horiguchi S, Sawahara H, Uchida D, Nagahara T, Iwamuro M, Morimoto H, Takeuchi Y, Kuwaki K, Kuwaki K, et al: [Corrigendum] Loss of Runt‑related transcription factor 3 induces resistance to 5‑fluorouracil and cisplatin in hepatocellular carcinoma. Oncol Rep 37: 1921-1921, 2017
APA
Kataoka, J., Shiraha, H., Horiguchi, S., Sawahara, H., Uchida, D., Nagahara, T. ... Okada, H. (2017). [Corrigendum] Loss of Runt‑related transcription factor 3 induces resistance to 5‑fluorouracil and cisplatin in hepatocellular carcinoma. Oncology Reports, 37, 1921-1921. https://doi.org/10.3892/or.2017.5419
MLA
Kataoka, J., Shiraha, H., Horiguchi, S., Sawahara, H., Uchida, D., Nagahara, T., Iwamuro, M., Morimoto, H., Takeuchi, Y., Kuwaki, K., Onishi, H., Nakamura, S., Takaki, A., Nouso, K., Yagi, T., Yamamoto, K., Okada, H."[Corrigendum] Loss of Runt‑related transcription factor 3 induces resistance to 5‑fluorouracil and cisplatin in hepatocellular carcinoma". Oncology Reports 37.3 (2017): 1921-1921.
Chicago
Kataoka, J., Shiraha, H., Horiguchi, S., Sawahara, H., Uchida, D., Nagahara, T., Iwamuro, M., Morimoto, H., Takeuchi, Y., Kuwaki, K., Onishi, H., Nakamura, S., Takaki, A., Nouso, K., Yagi, T., Yamamoto, K., Okada, H."[Corrigendum] Loss of Runt‑related transcription factor 3 induces resistance to 5‑fluorouracil and cisplatin in hepatocellular carcinoma". Oncology Reports 37, no. 3 (2017): 1921-1921. https://doi.org/10.3892/or.2017.5419